Pamela Esposito Kymera Therapeutics, Inc. (KYMR) insider trading activity

KYMR Quotes by TradingView

Pamela Esposito is of Kymera Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KYMR, which is worth approximately $0. The most recent transaction as insider was on Dec 02, 2024, when has been sold 2,500 shares (Common Stock) at a price of $49.0 per share, resulting in proceeds of $122,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
n/a 12M change
Total Value Held $0

Pamela Esposito Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 02 2024
SELL
Open market or private sale
$122,500 $49.0 p/Share
2,500 Reduced 100.0%
0 Common Stock
Dec 02 2024
BUY
Exercise of conversion of derivative security
$73,875 $29.55 p/Share
2,500 Added 50.0%
2,500 Common Stock
Sep 17 2024
SELL
Open market or private sale
$651,375 $48.25 p/Share
13,500 Reduced 100.0%
0 Common Stock
Sep 17 2024
BUY
Exercise of conversion of derivative security
$295,245 $21.87 p/Share
13,500 Added 50.0%
13,500 Common Stock

Also insider at

REPL
Replimune Group, Inc. Healthcare
Chief Business Officer
PE

Pamela Esposito

Watertown, MA

Track Institutional and Insider Activities on KYMR

Follow Kymera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

News

Receive news related to Kymera Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KYMR